NKD2 and osteosarcoma: In similar work, Zhao et al performed microarray analysis of an osteosarcoma genetically engineered mouse model, comparing localized vs metastatic tumors and found downregulation of NKD2, a negative regulator of Wnt signaling, in metastatic tumors compared with localized tumors [12].